Vitamin D receptor Cdx-2-dependent response of central obesity to Vitamin D intake in the subjects with type 2 diabetes: A randomised clinical trial

British Journal of Nutrition

Volumn 114, Issue 9, 2015, Pages 1375-1384

  Shab Bidar, Sakineh ^a   Neyestani, Tirang R ^b   Djazayery, Abolghassem ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiposity; Fat mass; Type 2 diabetes; Visceral fat; Vitamin D; Vitamin D receptor; Vitamin D receptor genotype

Indexed keywords

COLECALCIFEROL; TRANSCRIPTION FACTOR CDX2; VITAMIN D RECEPTOR; YOGHURT; CALCITRIOL RECEPTOR; CDX2 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; HOMEODOMAIN PROTEIN;

ADULT; ARTICLE; BODY FAT; CONTROLLED STUDY; FAT MASS; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRUNCAL FAT; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; BLOOD; BODY MASS; BODY WEIGHT; CALORIC INTAKE; DIET SUPPLEMENTATION; DIET THERAPY; DOSE RESPONSE; GENETICS; GENOTYPING TECHNIQUE; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; NUTRIGENOMICS; NUTRITIONAL ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE BLIND PROCEDURE; VITAMIN D DEFICIENCY;

ADIPOSITY; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CHOLECALCIFEROL; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY INTAKE; FEMALE; FOOD, FORTIFIED; GENOTYPING TECHNIQUES; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; NUTRIGENOMICS; NUTRITION ASSESSMENT; OBESITY, ABDOMINAL; PATIENT COMPLIANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, CALCITRIOL; SINGLE-BLIND METHOD; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; YOGURT;

EID: 84944274360     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515003049     Document Type: Article

References (48)

1. Kelishadi R, Alikhani S, Delavari A, et al. (2008) Obesity and associated lifestyle behaviours in Iran: findings from the first national non-communicable disease risk factor surveillance survey. Public Health Nutr 11, 246-251.
2. Salekzamani S, Neyestani TR, Alavi-Majd H, et al. (2011) Is vitamin D status a determining factor for metabolic syndrome? A case-control study. Diabetes Metab Syndr Obes 4, 205-212.
3. Hill JO & Peters JC (1998) Environmental contributions to the obesity epidemic. Science 280, 1371-1374.
4. Dennis KE (2007) Postmenopausal women and the health consequences of obesity. J Obstet Gynecol Neonat Nurs 36, 511-519.
5. Arunabh S, Pollack S, Yeh J, et al. (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88, 157-161.
6. Kamycheva E, Joakimsen RM & Jorde R (2003) Intakes of calcium and vitamin D predict body mass index in the population of Northern Norway. J Nutr 133, 102-106.
7. Wortsman J, Matsuoka LY, Chen TC, et al. (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690-693.
8. Young KA, Engelman CD, Langefeld CD, et al. (2009) Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 94, 3306-3313.
9. Parikh SJ, Edelman M, Uwaifo GI, et al. (2004) The relationship between obesity and serum 1, 25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89, 1196-1199.
10. Hajer GR, van Haeften TW & Visseren FL (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29, 2959-2971.
11. Zemel MB & Miller SL (2004) Dietary calcium and dairy modulation of adiposity and obesity risk. Nutr Rev 62, 125-131.
12. Soares M, Ping-Delfos WCS & Ghanbari M (2011) Calcium and vitamin D for obesity: a review of randomized controlled trials. Eur J Clin Nutr 65, 994-1004.
13. Caan B, Neuhouser M, Aragaki A, et al. (2007) Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med 167, 893-902.
14. Wood RJ (2008) Vitamin D and adipogenesis: new molecular insights. Nutr Rev 66, 40-46.
15. Kong J & Li YC (2006) Molecular mechanism of 1, 25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 290, E916-E924.
16. Burton GR, Guan Y, Nagarajan R, et al. (2002) Microarray analysis of gene expression during early adipocyte differentiation. Gene 293, 21-31.
17. Yamamoto H, Miyamoto KI, Li B, et al. (1999) The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Miner Res 14, 240-247.
18. Zemel MB, Shi H, Greer B, et al. (2000) Regulation of adiposity by dietary calcium. FASEB J 14, 1132-1138.
19. Ochs-Balcom HM, Chennamaneni R, Millen AE, et al. (2011) Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr 93, 5-10.
20. Rosenblum JL, Castro VM, Moore CE, et al. (2012) Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am J Clin Nutr 95, 101-108.
21. Neyestani TR, Djazayery A, Shab-Bidar S, et al. (2013) Vitamin D receptor Fok-I Polymorphism modulates diabetic host response to vitamin D intake need for a nutrigenetic approach. Diabetes Care 36, 550-556.
22. Shab-Bidar S, Neyestani TR & Djazayery A (2011) Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: a study protocol for a randomized controlled clinical trial. BMC Endocr Disord 11, 12.
23. Prevention I & TYPE DO (2011) Standards of medical care in diabetes-2011. Diabetes Care 34, S11-S61.
24. Shab-Bidar S, Neyestani TR, Djazayery A, et al. (2011) Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med 9, 125.
25. Neyestani TR, Gharavi A & Kalayi A (2007) Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. Int J Vitam Nutr Res 77, 341-346.
26. Saintonge S, Bang H & Gerber LM (2009) Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics 123, 797-803.
27. Ross AC, Manson JE, Abrams SA, et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96, 53-58.
28. Hrebicek J, Janout Vr, Malincikova J, et al. (2002) Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 87, 144-147.
29. Deng HW, Shen H, Xu FH, et al. (2002) Tests of linkage and/or association of genes for vitamin D receptor, osteocalcin, and parathyroid hormone with bone mineral density. J Bone Miner Res 17, 678-686.
30. Yong Zou G & Donner A (2006) The merits of testing Hardy-Weinberg equilibrium in the analysis of unmatched case-control data: a cautionary note. Ann Hum Genet 70, 923-933.
31. Freedman BI, Wagenknecht LE, Hairston KG, et al. (2010) Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 95, 1076-1083.
32. Looker AC (2005) Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab 90, 635-640.
33. Rajakumar K, de Las Heras J, Chen TC, et al. (2011) Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab 96, 1560-1567.
34. Cheng S, Massaro JM, Fox CS, et al. (2010) Adiposity, cardi-ometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 59, 242-248.
35. Caron-Jobin M, Morisset AS, Tremblay A, et al. (2011) Elevated serum 25 (OH) D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity 19, 1335-1341.
36. Sneve M, Figenschau Y & Jorde R (2008) Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 159, 675-684.
37. Zittermann A, Frisch S, Berthold HK, et al. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89, 1321-1327.
38. Zemel MB (2003) Mechanisms of dairy modulation of adiposity. J Nutr 133, 252S-256S.
39. Veilleux A, Rhéaume C, Daris M, et al. (2009) Omental adipose tissue type 1 11β-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women. J Clin Endocrinol Metab 94, 3550-3557.
40. Veilleux A, Laberge PY, Morency J, et al. (2010) Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue. J Steroid Biochem Mol Biol 122, 28-34.
41. Wehr E, Trummer O, Giuliani A, et al. (2011) Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol 164, 741-749.
42. Gu J-m, Xiao W-j, He J-w, et al. (2009) Association between VDR and ESR1 gene polymorphisms with bone and obesity phenotypes in Chinese male nuclear families. Acta Pharmacol Sin 30, 1634-1642.
43. Jain R, von Hurst PR, Stonehouse W, et al. (2012) Association of vitamin D receptor gene polymorphisms with insulin resistance and response to vitamin D. Metabolism 61, 293-301.
44. Arai H, Miyamoto KI, Yoshida M, et al. (2001) The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res 16, 1256-1264.
45. Arai H, Miyamoto KI, Taketani Y, et al. (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12, 915-921.
46. Beydoun MA, Tanaka T, Beydoun HA, et al. (2013) Vitamin D receptor and megalin gene polymorphisms are associated with central adiposity status and changes among US adults. J Nutr Sci 2, e33.
47. Uitterlinden AG, Fang Y, van Meurs JB, et al. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338, 143-156.
48. Newton R, Alfonso A, White M, et al. (2005) Percent body fat measured by BIA and DEXA in obese, African-American adolescent girls. Int J Obes 29, 594-602.